BREAKING
Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 19 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 21 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 21 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 days ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 2 days ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 days ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 days ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 19 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 21 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 21 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 days ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 2 days ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 days ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 days ago
ADVERTISEMENT
Market News

PetMed (PETS) Q3 earnings drop but beat Street view; sales miss

Earnings of PetMed Express Inc. (NASDAQ: PETS) decreased in the third quarter even as net sales remained unchanged. The bottom line, however, exceeded the market’s expectations. Net income dropped to $6.8 million or $0.34 per share in the third quarter from $7.7 million or $0.38 per share a year earlier. Earnings, however, exceeded analysts’ forecast. […]

$PETS January 21, 2020 2 min read

Earnings of PetMed Express Inc. (NASDAQ: PETS) decreased in the third quarter even as net sales remained unchanged. The bottom line, however, exceeded the market’s expectations.

Net income dropped to $6.8 million or $0.34 per share in the third quarter from $7.7 million or $0.38 per share a year earlier. Earnings, however, exceeded analysts’ forecast. At $59.9 million, net sales were broadly flat year-over-year but below the market’s expectations.

Order Growth

During the three-month period, the average order size edged up to $85 from $84 last year. Reorder sales increased 1% annually to $53.8 million.

Related: PetMed Q2 Earnings Conference Call Transcript

The management’s successful efforts to establish direct purchasing relationships with leading manufacturers and the implementation of minimum advertised price policy have translated into margin growth. Total operating expenses decreased 2% to $9.8 million.

ADVERTISEMENT

Competition

Of late, the company has been focused on marketing and promotional activities as it continues to face stiff competition from rival pet pharmacy Chewy (CHWY). Last month, Chewy reported a net loss for its third quarter, despite an increase in sales. The bottom line was impacted by higher operating expenses.

“In 2020, we will focus on optimizing our marketing in this more competitive environment and being more efficient with our advertising spending. In addition, we will continue investing in our e-commerce platform to better service our customers. This platform will enable us to improve upon our already strong net promoter score of 84.0%.“ said PetMed’s CEO Menderes Akdag.

Dividend

In the third quarter, PetMed’s board of directors declared a quarterly cash dividend of $0.27 per share, which will be paid on February 14, 2020, to shareholders of record on February 3, 2020.

Also read: Retail space gets busy as firms see new opportunities

Last week, PetMed shares climbed to the highest level in twelve months. The stock closed the last trading session notably higher but traded lower during Tuesday’s premarket trading hours. Since the beginning of the year, it gained about 17%.

ADVERTISEMENT

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text

ADVERTISEMENT